Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024695
Filing Date
2022-11-14
Accepted
2022-11-14 07:31:24
Documents
62
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tcrt-20220930.htm   iXBRL 10-Q 2463749
2 EX-3.1 tcrt-ex3_1.htm EX-3.1 187931
3 EX-31.1 tcrt-ex31_1.htm EX-31.1 16662
4 EX-32.1 tcrt-ex32_1.htm EX-32.1 8792
5 GRAPHIC img159889792_0.jpg GRAPHIC 283337
6 GRAPHIC img159889792_1.jpg GRAPHIC 222710
7 GRAPHIC img159889792_2.jpg GRAPHIC 213912
8 GRAPHIC img159889792_3.jpg GRAPHIC 267427
9 GRAPHIC img159889792_4.jpg GRAPHIC 224449
  Complete submission text file 0000950170-22-024695.txt   10528149

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tcrt-20220930_def.xml EX-101.DEF 273201
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcrt-20220930.xsd EX-101.SCH 58187
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcrt-20220930_pre.xml EX-101.PRE 358404
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcrt-20220930_lab.xml EX-101.LAB 467888
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tcrt-20220930_cal.xml EX-101.CAL 32762
56 EXTRACTED XBRL INSTANCE DOCUMENT tcrt-20220930_htm.xml XML 991203
Mailing Address 8030 EL RIO STREET HOUSTON TX 77054
Business Address 8030 EL RIO STREET HOUSTON TX 77054 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 221380279
SIC: 2834 Pharmaceutical Preparations